Cardiovascular System Flashcards

1
Q

What is arrhythmia?

A

Abnormal rhythm and rate
Due to problems with the electrical conducting system of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Symptoms of arrhythmias

A

Palpitations
Abnormally fast, slow or irregular pulse
Dizziness or feeling faint
Shortness of breath
Chest pain which sometimes develop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What can cause arrhythmias?

A

May occur as complications of heart conditions
Coronary heart disease
Heart valve disease
Hypertension
Ageing
Cardiomyopathy (disorder of the heart muscle)
Congenital (from birth) abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Different types of arrhythmias?

A

Ectopic beat
AF (main one for the exam)
Paroxysmal AF
Atrial flutter
Paroxysmal supraventricular tachycardia
Ventricular tachycardia
Supra ventricular arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Treatment of arrhythmias?

A

Medication
Cardio version
Artificial pacemakers
Implantable cardioverter defibrillation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Aims of treatment of arrhythmias?

A

Reduce symptoms
Prevent complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What risk calculators are needed for AF?

A

Stroke risk
Bleeding risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is stroke risk calculated?

A

CHA2DS2-VASc
Risk factors; CHF, hypertension, Age (75+ 2 points 65-74 is 1), Diabeties, stroke/TIA/VTE , vascular disease, sex (female is 1)
Low risk = men score of 0 and women with score 1
Higher points would require treatment with anticoagulation as long as risk > than risk of bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is bleeding risk calculated?

A

Has bled tool replaced by ORBIT
Score of 0-7
Factors; males with HBA1C <130 g/L or females <120, prior history of bleeding, age > 74, EGFR <60 mL/min/1.73m2 and taking anti platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is torsade de pointes?

A

Prolonged QT interval
Self limiting
Can lead to ventricular fibrillation
Treat IV Mg sulphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What drugs are used in rate control?

A

Beta blockers (NOT sotalol)
Verapamil
Diltiazem (unlicensed)
Drug treatment usually mono-therapy but combine if mono-therapy fails
Digoxin only considered for initial rate control with non paroxysmal AF with predominantly sedentary or others is unsuitable, accompanied by HF and AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Drugs used for rhythm control after cardioversion?

A

1st line is Beta blockers
If not
Flecanide
Amiodarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When to avoid flecanine

A

Avoid if also have isachaemic or structural heart disease, HF etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How to treat supraventricular arrhythmias?

A

Verapamil, adenosine and cardiac glycosides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How to treat ventricular arrhythmias?

A

Lidocaine and sotalol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How to treat supraventricular and ventricular arrhythmias ?

A

Amiodarone and beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is digoxin?

A

Cardiac glycoside
Increases force of myocardial contraction and reduces conductivity in a the atrio ventricular node
Useful in controlling AF, atrial flutter and HF (for pts with sinus rhythm)
Has a long half life maintenance dose around 125-250 mcg)
Dose dependent on renal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the therapeutic range of digoxin?

A

0.7 to 2.0 nano grams / mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is toxicity level of digoxin?

A

1.5 to 3
Toxicity can occur within normal range (0.7 - 2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Contraindications for digoxin?

A

Ventricular tachycardia and fibrillation
Heart conduction problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Signs of digoxin toxicity?

A

Arrhythmias
Cardiac conduction disorder
Diarrhoea
Dizziness
Nausea and vomiting
Skin reactions
Vision disorders (yellow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Risk factors of digitalis toxicity?

A

Hypokalaemia
Hypomagnesaemia
Hypercalcaemia
Hypoxia
Special care in elderly; more susceptible to digitalis reduce dose as they have poor reduced kidney function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Interactions with digoxin

A

CCB (increase concentration)
Rifampicin (decrease concentration)
Amiodarone (half the digoxin dose)
St John’s wart (decrease concentration)
Erythromycin
Diuretics
TCS, venlaflaxine, TCA, venlafaxine, trazadone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What happens if digoxin toxicity occurs?

A

Withdraw digoxin
Serious manifestations require urgent specialist care
Life threatening overdose - reverse with digoxin specific antibody fragments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Monitoring requirements for digoxin?
Plasma- digoxin concentration Serum electrolytes Renal function (reduce dose in renal impairment)
26
Tranexamic Acid
Inhibits fibrinolysis (prevents you from bleeding) Prevents bleeding (e.g surgery, dental extraction) Management of menorrhagia ( 1 g TDS for up to 4 days) Used in hereditary angioedema, epistaxis and thrombocytes overdose
27
Two types of venous thromboembolism?
DVT clot in body usually the legs PE blockage of artery in lungs
28
Venous thromboembolism prophylaxis
All patients admitted to hospital need to be assessed for their risk of VT on admission
29
Who are high risk for VT?
Substantial reduction in mobility Obesity >30 BMI Malignant disease Hx of VT Thrombophilic disorder Patient over 60 years Pregnancy / co-morbidities
30
Mechanical prophylaxis for venous thromboembolism?
Anti embolism stockings Continue until patients is mobile Move around and raise legs etc
31
Pharmacological PROPHYLAXIS for venous thromboembolism?
Undergoing general orthopaedic surgery who are at high risk Choice depends on type of surgery Stop depends on condition / surgery or when patient mobile again (no fixed time) LMWH suitable for all types of patients e.g dalteparin, tinzaparin and enoxaparin Fondaparinux sodium to patients undergoing (hip/knee replacement surgery, hip fracture, GI bariatic) Oral anticoagulation for thromboprophylaxis following knee / hip surgery
32
Treatment for Venous thromboembolism?
Use LMWH (enoxaparin, dalteparin and tinzaparin) for initial treatment of DVT and PE Give IV unfractionated heparin as alternative Start oral anticoagulant (usually warfarin) at same time as LMWH or unfractionated heparin; once out of hospital continue oral
33
Venous thromboembolism in pregnancy
Heparins don’t cross the placenta LMWH preferred (lower risk of osteoporosis and of heparin induced thrombocytopenia) and are eliminated more rapidly in pregnancy, dose alteration is required
34
What are LMWH?
Dalteparin Tinzaparin Enoxaparin
35
What is common side effect of LMWH?
Haemorrhage - Withdraw heparin or LMWH if this occurs Osteoporosis Heparin-induced thrombocytopenia (can manifest 5 to 10 days after) Hyperkalaemia; heparin inhibits aldosterone secretion, high risk DM and CKD monitor 7+ day use
36
What is reversal agents for LMWH?
Promoting sulphate Partial reversal agent
37
3 types of strokes
Transient ischaemic stroke (TIA); aka mini stroke <24 h Intracerebral haemorrhage Acute isachaemic stroke (full blown stroke) >24 H
38
Signs of stroke
Face dropped Arm weakness Speech slurred Time (999) F.A.S.T
39
TIA treatment
300 mg Aspirin daily OR alternatively 75 mg clopidogrel immediately until established diagnosis Once diagnosed; Secondary prevention; High intensity statin if not already taking Symptoms usually resolve within minutes or a few hours at most if not = STROKE
40
Short term treatment of Acute Isachaemic stroke?
Timing important; Alteplase within 4.5 hours from onset of symptoms 300 mg Aspirin or clopidogrel given 24 hours after alteplase for 14 days Anticoagulants not recommended except for patients with AF
41
Long term management for isachaemic stroke?
Clopidogrel MR dipyridamole 200 mg and aspirin IF clopidogrel is CI MR dipyridamole alone IF aspirin and clopidogrel is CI Aspirin alone IF clopidogrel and dipyridamole is CI High intensity statin treatment 48 hours after Monitor BP target for <130/80 mmHg Advice patients on lifestyle changes (modify diet, exercise, weight alcohol intake, smoking)
42
Intracerebral haemorrhage treatment
Surgery to remove haematoma and relieve intracranial pressure DONT GIVE ANTICOAGULANTS - reverse effects expect for pts DVT/PE not given even in AF patients Avoid statins unless CV event outweighs risk of haemorrhage Aspirin only given with patients of cardiac isachaemic event BP measured and treatment initiated
43
What are anticoagulants used for?
Prevent thrombus formation in veins Examples. Warfarin, acenococoumarol and phenindione Antagonise vitamin K Takes at least 48 to 72 hours to get the full effect (oral) Injections give a immediate effect e.g give heparins
44
Pregnancy and warfarin
Teratogenic Cross the placenta leading to foetal abnormalities Avoid esp in the 1st and 3rd trimester and last few weeks of pregnancy as delivery as increase in bleeding risk Risk of haemorrhage increased by vitamin K deficiency
45
Interactions with warfarin?
Increase warfarin; miconazole, antifungals, benzafibrate, amiodarone, cranberry juice, pomegranate, greeny fruit and veg Increases bleeding risk; antidepressants, aspirin Decreases warfarin; carbamazepine, alcohol, St John’s wart
46
MHRA warnings with warfarin?
Risk interactions with treatment of hepatitis C- closely monitor INR Calciphylaxis - rare skin rash
47
Warfarin target value INR 2.5 for?
Treatment of DVT and PE AF Cardioversion Dilated cardiomyopathy Mitral stenosis
48
Warfarin INR target value of 3.5 ?
Recurrent DVT and PE or mechanical prosthetic heart valve
49
What is a target value?
Target the INR should be rather than a given range INR measured can be 0.5 above and below the target value if more = adjustment is required from the dose
50
Warfarin advantages and disadvantages?
+ can be used renal impairment patients + effects are reversible - regular INR testing - lots food and drug interactions
51
Warfarin main side effects
Nose bleeds; < 10 mins is normal Haemorrhage Bleeding gums Bruising Caliphylaxisl report painful skin rash = risk factor end stage renal disease
52
When to stop warfarin
Bleeding OR if INR is >8; stop warfarin and give vitamin K by IV (restart INR <5) No bleeding and INR >8; stop warfarin and given vitamin K orally (restart INR <5) No bleeding and INR 5-8; withold one or two doses and reduce subsequent maintenance doses
53
Peri operative anticoagulants
Stop warfarin 5 days before elective (planned) surgery High risk patients of VT stopping warfarin before surgery maybe given LMWH which is stopped 24 hours before surgery Emergency surgery which can be delayed 6-12 hours give IV vitamin k If surgery cant be delayed give vitamin K and prothrombin complex
54
Anticoagulant and antiplatelet therapy?
Higher risk of bleeding with clopidogrel and warfarin than aspirin and warfarin
55
Heparin
Short duration of action compared LMWH ‘Standard’ - unfractionated Used for high risk patients as its effects are shorter; but this means more doses Can be used in pregnancy doesn’t cross the placenta
56
LMWH examples
Dalteparin, enoxaparin and tinzaparin
57
LMWH used?
Used prophylaxis and treatment of DVT, PE and MI Preferred over heparin; effective and lower risk of heparin-induced thrombocytopenia Doesn’t require monitoring Longer duration of action then heparins can be given OD s/c = convenient
58
Antiplatelets used for?
aspirin, clopidogrel and dipyridamole Decrease platelet aggregation and inhibit thrombus formation in the arterial circulation No benefit for primary prevention only secondary PPI given for patients high risk of bleeding (over 65+, NSAIDs etc)
59
Rivaroxaban
MHRA alert; strengths 15 mg+ to be taken with food Prophylaxis of stroke and systemic embolism in patients with non-valvular AF with at least 2 of the following risk factors; CHF, hypertension, previous stroke/TIA, age > 75 or DM S/e; anaemia, constipation, diarrhoea, dizziness, headache
60
Apixaban
Reduced to 2.5 BD for prophylaxis of stroke due to non-valvular AF with at least 2 of the following; Age (80+), Body weight (less 60) CrCl (greater 133) Otherwise 5 mg is standard dose S/e; anaemia, haemorrhage, nausea and skin reactions
61
Edoxaban
Prophylaxis of stroke and systemic embolism in non-valvular AF, in patients with at least one risk factor such as CHF, hypertention, age 75+, DM, previous stroke or TIA 30 mg OD body weight up to 61 kg OR 60kg and above S/e abdominal pain, anaemia, dizziness, haemorrhage, headache, nausea, skin reactions
62
Dabigatran etexilate
Avoid CrCl less 30 mL/min ; assess renal function before at least annually Prophylaxis of stroke and systemic embolism in non-valvular AF and with one or more risk factors such as previous stroke or TIA symptomatic HF, age 75+, DM or hypertention Special container 4 months expiry S/E; anaemia, diarrhoea, GI discomfort, haemorrhage
63
Reversal agents for DOACS
Apixaban and rivaroxaban; Andexanet Alfa (ondexxya) Dapigatran etexilate; idarucizumab (praxbind) Edoxaban has no reversal agent
64
Dabigatran, apixaban and rivoroxaban
Direct thrombin inhibitors (factor Xa) Rapid onset of action Prophylaxis VTE in adults after hip/knee surgery and prophylaxis of stroke and systemic embolism FBC, LFT and U&E recommended annually if not renal impairment (more U&E if renal impairment) Limited by renal impairment Monitor signs; bleeding, anaemia, stop if severe bleeding occurs Common s/e haemorrhage
65
What patients are high risk of developing hyperlipidaemia?
Diabeties Chronic kidney disease Familial hypercholestrolaemia Risk increases with age (>85 years at high risk esp if smoke/hypertention) 10 year risk of CVD >10% Drugs; antipsychotics, immunosuppressants, corticosteroids, antimalarials
66
CVD measures for primary prevention
Provide lifestyle advice to all patients at high risk; diet, exercise, weight management If above not effective give statins as first line choice
67
CVD measures for secondary prevention
Offer statins to ALL
68
Statins for CVD
Statins reduce the risk of CVD 1st drug of choice in primary and secondary prevention CVD Address secondary causes of dyslipidaemia before starting statins (uncontrolled DM, hepatic disease, nephrotic syndrome and excessive alcohol consumption) Correcting hypothyroidism may resolve lipid abnormality (treat patients itch hypothyroidism with thyroid replacement first)
69
What is a high intensity statin?
Atorvastatin; 20 mg, 40 mg and 80 mg Rosuvastatin; 10 mg, 20 mg and 40 mg Simvastatin; 80 mg
70
Primary prevention for statins for CVD
Give high intensity statin for 10 year risk >10% High intensity statin is one that produces a greater LDL-cholesterol reduction than simvastatin 40 mg (or = greater atorvastatin 20 mg) Patients over 35 years help reduce risk of non fatal MI
71
Secondary prevention with statin for CVD
Atorvastatin 80 mg recommended Give statins to all patients with type I diabeties (esp those > 40 years and have diabeties for over 10 years, established nephropathy or other risk factors
72
Statin and blood test
Total cholesterol HDL cholesterol Non HDL cholesterol 3 months after starting
73
Types of cholesterol
Total cholesterol; total cholesterol in your blood (5 or below) HDL; good cholesterol (1/+) LDL or non-HDL; bad cholesterol (3 or below for LDL and 4 or below for non HDL) Triglycerides; 2.3 or below (fat lipids)
74
Diagnosis for hyperlipidaemia
6 mmol/L total cholesterol
75
Treatment lines for high lipids?
First line statins Second line is ezetimbe (if statin not effective or CI) Fenofibrate maybe added to statin if triglyceride is high (SPECIALIS USE NOW) Then consider nicotine acids, bile and sequestration and omega 3 fatty acid compounds
76
Statin and fibrate interaction
Statin + fibrate (or nicotine acid) increase risk of s/e; rhabdomylosis Especially statin + gemfibrozil (fibrate) increase rhabdomylosis considerably
77
Which statins can be taken at any time during the day?
Rosuvastatin and atorvastatin
78
Statins and pregnancy
Adequate contraception is required during treatment and 1 month after Avoided in pregnancy Discontinue 3 months before conceiving attempt Congenital abnormalities and the decrease synthesis of cholesterol can possibly affect foetal development
79
Statin monitoring requirements
Full lipid profile and LFT before treatment, at 3 months and then 12 months Creatinine kinase only for patients with unexplained muscle pain; if results are x5 normal range = discontinue and reintroduce if still high stop Monitor liver function Address any secondary causes first
80
Can you use statins in hepatic impairment?
Use in caution in those with liver disease Avoid in active liver disease or unexplained elevations in serum transaminase
81
Side effects of statins
Muscle toxicity (higher risk; family hx, high alcohol intake, renal impairment) more likely in high doses Pt to report any unexplained muscle pain, tenderness or weakness Simvastatin 80 mg MHRA; Rhabdomylosis
82
Simvastatin dose
10-20 mg at night (increase to 80 mg) primary hypercholestolaemia 40 mg at night (can increase to 80 mg) homozygous familial hypercholestolaemia 20 - 40 mg at night increases prevention CV events in patient in DM or otherosclerotic CVD MAX 10 mg with fibronates
83
Atorvastatin dose
Primary prevention in CV events in patients with high risk CV events; 20 mg OD dose interval increase 4 weeks if necessary to 80 mg Secondary prevention CV event 80 mg daily Primary hypercholesterolaemia / heterozygous familial hypercholestalaemia 10 mg initially Max 10 mg with Ciclosporin
84
Rosuvastatin dose
Consider routine monitoring of renal function when using 40 mg daily 5 mg initially up to max 20 mg with clopidogrel
85
Simvastatin MHRA warning
Max dose 20 mg with Amlodopine, verapamil and amiodarone Higher doses are off license
86
Statin drug interactions
Carbamazepine; increase the risk of hepatotoxicity Clarithryomycin / erythromycin; increase exposure to simvastatin so stop whilst on treatment Grapefruit juice increases exposure and ketoconazole and miconazole Oral fusidic acid must be restated after 7 days of last dose
87
P450 inhibitors
Sodium valproate, Isonaside, Cimetidine, Ketoconazole, Fluconazole, Alchohol, Chlorepteniol, Erythromycin . Ciprofoxacin, Omeprzole Metronidazole SICKFACE.COM
88
P450 inducers
Carbamezapine, Rifampicin, Alcohol, Phenytoin, Grisefluvin Phenobarbital Sulphonylurea CRAP GPS
89
What is heart failure?
Heart isn’t functioning as well as it should; not working at its maximum capacity Acute Chronic
90
What is Acute HF?
Sudden Emergency - hospital admission required
91
What is Chronic HF?
Progressive Slow onset and gradual Can worsen and turn to acute
92
What is ejection volume?
How much blood the heart manages to pump out with each heart beat
93
Symptoms of HF
Breathlessness; may occur when you exert yourself, lay flat / wake up from sleep Fluid retention; swollen ankles, swelling of legs, bottom or tummy Lethargic Persistent cough / wheezing Light headed or dizzy or having faint spells Loss of appetite Constipation Reduced exercise tolerance Risk greater in men, smokers, diabetics and patients with higher age
94
What causes HF?
Coronary heart disease; most common cause especially after MI Cardiomyopathy; disease of the heart muscle not pumping effectively Hypertension esp in Afro-Caribbean origin Disease of the heart valves Arrhythmias Medicine that can damage the heart; cocaine, some chemo, excess alcohol Non-Heart related issues; thyroidism, severe anemia
95
Lifestyle advice for HF patients
Diet Exercise Smoking cessation Alcohol intake
96
Diagnosis for HF?
Physical; echocardiogram, fast pulse, signs of fluid retention Blood tests; high NT-proBNP Other tests; ECG, chest X-ray, urine, spirometer, breathing tests
97
New York classification HF
1) No symptoms normal during activities 2) comfortable at rest but symptoms at normal activities 3) comfortable at rest but symptoms at minor activity 4) discomfort at rest and at any level of activity
98
What is the main HF aims?
Relieve symptoms Improve exercise tolerance Reduce exacerbations
99
What is drug treatment for HF?
1) Offer diuretics for congestive symptoms and fluid retention (often loop); relieves breathlessness, oedema and fluid retention. Furosemide first choice followed by bumetinide or TLD if not worked 2) If HF with PRESERVED ejection fraction manage co-morbidities and offer cardiac rehab if stable 2) HF with REDUCED ejection fraction give ACEi/ARB and BB 3) if symptoms continue would give aldosterone antagonist such as spironolactone or eplerone 4) If symptoms not helping SPECIALIST CARE (digoxin, hydralazine, ivabradine and nitrates would be initiated)
100
What ACEi/ARB is used in HF?
Valsartan or candersartan
101
What beta blockers are used in HF?
Bisoprolol, carvidiol, nebivolol
102
What class of drugs should be avoided in HF?
CCB need to be avoided E.g verapamil / diltiazem and short acting dihydropyridlines e.g nifedipine and nicardipine as they reduce cardiac contractility
103
What are the three types of Acute Coronary Syndrome (ACS)?
Unstable angina NSTEMI ; non-ST elevated MI STEMI; ST elevated MI
104
Angina VS MI?
Angina is a partial block of blood into the heart MI is a complete block so no blood is getting to the heart muscles so they begin to die
105
What causes ACS?
Plaque ruptures from within the coronary artery Obstruction causes restriction of blood supply to the heart and lack of oxygen leads to isachaemic; angina is often first signs
106
STEMI Vs NSTEMI
STEMI; more serious; elevated ECG caused complete obstruction and cardiac cell muscles die NSTEMI; partial block heart attack in between angina and STEMI; some cells die some are ok
107
Symptoms of angina
Chest pain (tight, sharp stabbing, dull, heavy) Spread to L arm, neck, jaw or back Triggered by physical exertion or stress Stops within a few minutes of resting Nause Fatigue SOB Dizziness Sweating
108
Stable angina VS unstable angina
Stable angina is predictable; symptoms occur during exercise/activity/stress and stop on rest Unstable angina is unpredictable; occurs chest pain while resting pain last longer / more recurring and revere
109
Management of unstable angina and NSTEMI
1) OXYGEN is initial management 2) administer NITRATES if evidence of hypoxia, pulmonary oedema or continuing MI; to relieve isachaemic pain, give IV if sublingual not effective, if pain continues IV diamorphine or morphine or antiemetic 3) aspirin and clopidogrel (ticagrelor or prasugrel as alternative) 4) unfractionated heparin, LMWH or fondaparinux sodium
110
Prevention of CV events
Advise to reduce risk Lifestyle changes e.g stop smoking, weight loss, management other co-morbidities Long term management; consider statins, ACEi, aspirin, beta blockers
111
Angina prophylaxis
BB or CCB (e.g diltiazem, verapamil) Vasodilators; long acting nitrates, ivabradine, ranolazine Nicorandil
112
Nicorandil
MHRA; 2nd line risk of ulcer complications Caution; diverticula’s disease., HF, hyperkalaemia S/e; dizziness, haemorrhage, headache, nausea For long term angina treatment K channel activator with nitrate compound
113
Nitrates
For angina Coronary vasodilators but principle benefit is a reduction in venous return which reduces left ventricular work S/E; flushing, headaches and postural hypotension
114
Types of nitrates
Sublingual GTN most effective providing rapid symptom relief Tablet 300 mcg (P med) also available as 500 and 600 mcg Aerosol spray as an alternative for S/L Transdermal patches can also be used have a long duration of action Dinitrate MR preparations and mononitrate MR preparations
115
Dinitrate MR preparations
BD duration for 12 hours Not seen as much anymore Slow onset of action IV used more severe symptoms Dinitrate is broken down to mononitrate therefore activity depends production of active metabolite
116
Mononitrate MR preparations
OD Angina prophylaxis IM up to 2-3 times a day Less tolerance as if OD than BD/TDS
117
Nitrate tolerance
Need to keep a nitrate free period for 6-8 hours to prevent tolerance Pt on long acting or transdermal patches; develop tolerance (decreases therapeutic effect) if tolerance occurs = leave off patch for 8-12 hours in each 24 hours then put back on
118
Caution or further information nitrate
Don’t give conventional IR preps mononitrate; give MR OD to avoid tolerance, more than BD unless small doses Avoid abrupt withdrawal In case Dinitrate MR or conventional mononitrate second dose of BD should be given 8 hours after rather than 12 hours
119
GTN tablet dispensing and storage requirements
Available in strengths of 300, 500 and 600 mcg Supplied in glass container of no more than 100 Closed with foil line cap No cotton wool waddling Discard after 8 weeks Rectal ointment (rectogesic) should be discarded 8 weeks after opening
120
How to measure hypertention?
Home blood pressure monitoring (HBPM); standard machine Within a clinical setting Ambulatory 24 hour monitoring (ABPM); monitors automatically for the day
121
What are the risk factors for hypertension?
Main cause is unknown Age, ethnicity, dietary salt, exercise, alcohol, caffeine, smoking Secondary causes renal disease and endocrine causes
122
Which organs are ‘target organ damage’?
Heart Brain Kidney Eye
123
What is the normal blood pressure reading?
120/80 mmHg
124
Stages of hypertension
Stage 1; clinic BP >140 / 90 OR ambulatory/home reading >135/85 Stage 2; clinic BP > 160/100 OR ambulatory/home reading >150/95 Severe hypertention clinic systolic >180 OR ambulatory/home reading >110
125
What to do if high reading in clinic?
Offer ambulatory blood pressure monitor to confirm hypertension diagnosis Meanwhile; test for CV risk assessment, investigate target organ damage
126
What happens if hypertension is diagnosed?
Offer urine/blood test Lifestyle intervention Drug treatment
127
Stage 1 hypertention
Investigate for secondary causes of hypertension Pts with persistent stage 1 with one/+; target organ damage, established CVD, renal disease, diabeties Clinic BP >140/90 or ambulatory/home >135/85
128
Stage 2 hypertention
Treat all regardless of age Clinic BP >160/100 or amublatory/home >150/95
129
Severe hypertention
Treat promptly with IV antihypertensive Clinic systolic >180 mmHg or clinic diastolic >110
130
What is first line treatment for hypertention?
ACEi/ ARB if patient is diabetic or under 55 and not of Afro-Carribean CCB if patient is Afro-Caribbean or over the Agee 55+
131
What is 2nd and 3rd step intervention for hypertention?
ACEi/ARB + CCB OR CCB + thiazide like diuretic OR ACEi/ARB + thiazide like diuretic Thirst step; is all 3 together
132
Hypertension and HF patients
Don’t give CCB as it will make HF worse need to avoid Give ARBs or thiazide like diuretics
133
What is the 4th step stage for hypertention treatment?
Confirm resistant hypertention; confirm elevated BP with Ambuatory home blood pressure monitor Consider expert advice on adding; Low dose spironolactone if blood pottasoum is <4.5 Alpha blocker or BB if blood potassium is >4.5
134
Target clinic BP for hypertension in diabetics?
Target clinic of <140 / 80 OR <130 / 80 if kidney, eye or cerebrovascular disease present ACEi/ARB to manage nephropathy
135
Hypertension in pregnancy
ACEi / ARBs / thiazide like diuretics; increase congenital abnormalities 1) first choice is lobetalol to achieve BP <138/85 2) if unsuitable consider nifedipine MR (unlicensed manufacture avoid pre 20 weeks) 3) Methyldopa (unlicensed) to discontinue 2 days after birth and switch to alternative Methyldopa and lobetalol are the safest Review bp 2 weeks after birth and medication review 6-8 weeks
136
Breast feeding and hypertention
Enalapril Treat hypertention in post natal period For black afro give amlodipine/ nifedipine
137
BB mechanism of action
Block beta adrenoceptors in the heart, bronchi, pancreas, liver and peripheral vasculature Slow the heat B1 receptors in the heart B2 receptors in the lungs
138
ISA activity BB
ICE PACO Pindolol, Acebutolol, Celiprolol, Oxprenolol Causes less bradycardia and less coldness of extremities
139
Soluble BB
WATER CANS Celiprolol, Atenolol, Nadolol, Sotalol Less likely to enter the brain Causes less sleep disturbances and nightmares; used to treat these conditions Excreted in the kidneys; decrease dose in impairment
140
Cardioselective BB
BATMAN Bisoprolol Atenolol T Metoprolol Acebutol Nebivolol Less effects on airways, selective but not specific, higher affinity for B1 heart receptor
141
Long duration BB
BACON Bisoprolol Atenolol Celiprolol O Nadolol Once daily preparations
142
Sotalol
Rejected child Non cardioselective Causes bronchospasm Not to be used for asthmatics
143
Side effects for BB
Fatigue Coldness of extremities (less common ISA) Sleep disturbances (less common water soluble) Bradycardia Bronchospasm Claudication Vivid dreams Diziness,
144
Patient and carer advice for BB
Do not stop abruptly due to risk of worsening ischaemic heart disease
145
Contraindication and caution with BB
ABCDE Asthma Block (heart); avoid unstable HF, 2/3rd degree heart block COPD Diabeties - avoid in patients with frequent episodes of hypoglycaemia as it masks symptoms Electrolyte disturbances (hyperkaemia)
146
Side effects BB in asthmatics
Precipitate bronchospasm Can be given if asthma is well controlled For co-existing conditions e,g HF or following MI; give cardioselective
147
Are BB contra indicated in diabetics?
Caution in use Affects carbohydrate metabolism Avoid in patients with frequent hypoglycaemia episodes; can masks symptoms of hypoglycaemia e.g tachycardia
148
BB uses
Hypertention - reduce cardiac output Angina - improve exercise tolerance and angina MI - reduce recurrence rate; atenolol metoprolol Arrhythmias - esmolol sotalol HF; only in stable HF Bisoprolol, carvediol, nebivolol Anxiety, migraine or thyrotoxicosis give propranolol Glaucoma give timolol
149
BB and verapamil
AVOID Precipitate HF or cause AV block Risk hypotension and HF Verapamil is highly negative ionotropic; slows heart rate Is a CCB
150
BB drug interactions
Aminophylline Amiodarone Diltiazem Digoxin Flecainide Theophylline Verapamil
151
CCB classes
Dihydropyridines - act on blood vessels more peripherally e.g amlodipine, nifedipine, lercanidipine etc Phenylaklyamines - work mainly heart e.g verapamil Benzothiazepines - works in between both classes; both cardiac depressants and vasodilators effects e.g diltiazem
152
How does CCB work
Blocking calcium entry into cells decreasing the contraction of smooth muscle which lines blood vessels
153
Side effects of CCBs
Vasodilators effects Diziness Flushing Headaches Postural hypotension GI disorders Ankle swelling Skin reactions
154
Contraindications and cautions in CCB?
HF Hepatic impairment; avoid nifedipine Renal impairment
155
Withdrawal of CCB
Sudden withdrawal may exacerbate angina
156
Diltiazem prescribing and dispensing information
Different version of MR preparation contains more than 60 mg may not have same clinical effect Prescribe by Brand
157
Thiazide and related diuretics mechanism of action?
Works by reducing re absorption of electrolyse in the renal tubules main sodium and chloride Used for hypertension and oedema
158
How long do thiazide diuretics take to work?
Act within 1 to 2 hours Effects lasts for 12 to 24 hours (longer duration than loop)
159
Patient and carer advice for thiazide and related diuretics?
Give in the morning to avoid diuresis at night Moderately potent Be aware of postural hypotension ensure dose is taken in the morning Elderly more susceptible to s/e so give lower initial dose Adjust dose in response to renal function
160
Adverse diuretic effects
Postural hypotension HYPERglycaemia HYPOkalaemia HYPOnatraemia HYPOmagnesaemia HYPERcalcaemia GI disturbances Cardiac arrhythmias Dizziness and headache
161
Which diuretics have higher HYPOkalaemia risk?
Greater in thiazide than loop Hypokalaemia in hepatic failure can lead to encephalopathy particularly in alcoholic cirrhosis
162
What conditions can thiazides exacerbate?
Thiazide and related diuretics can exacerbate diabeties and gout
163
Pregnancy and thiazide and related diuretics
Should not be used for gestational hypertention Can cause; neonatal thrombocytopenia, bone marrow suppression, jaundice and electrolyte imbalances
164
Hepatic and renal impairment in diuretics
Use with caution and avoid in severe liver disease Ineffective in EGFR <30 and should be avoided
165
Loop diuretics
E.g furosemide and bumetanide Used in pulmonary oedema due to left ventricular failure and in CHF Stronger than thiazides and can be used for resistant oedema Can exacerbate diabeties Work within 1 hour and last up to 6 hours
166
Contra indications in loop diuretics
Renal failure Severe hypokalaemia Severe hyponatraemia Liver cirrhosis
167
Renal impairment and loop diuretics
High doses or rapid IV administration can cause tinnitis and deafness (ototoxicity)
168
Thiazide and related diuretics interactions
Medications that lower blood pressure Amisulpride Amino and theophylline NSAID Amiodarone Digoxin TCAs Lithium
169
What drugs should be given with potassium sparing diuretics?
E.g of K sparing epelerone, spironolactone, amiloride etc Potassium supplements = hyperkalaemia ACEi = can cause severe hyperkalaemia
170
Mannitol
Osmotic diuretic used to treat cerebral oedema and raised IOP
171
Acetazolamide
Carbonic anhydrase inhibitor Weak diuretic Used for motion sickness prophylaxis
172
Dorzolomide and brinzolomide
Acts as diuretics by inhibiting formation of aqueous humour and used in glaucoma
173
ACEi mechanism of action
Inhibit conversion of angiotensin I to angiotensin II (prevents breakdown of bradykinin = lowering bp)
174
ACEi indications
Hypertention HF Secondary prevention of CV events Nephropathy
175
Contraindications of ACEi use
Afro-Caribbean origin; increased risk of angioedema Previous or family hx of angioedema Pregnancy and breastfeeding Renal impairment due to increased risk of hyperkalaemia Not to be used with alskinen EGFR <60
176
When to take ACEi
First dose hypotension ; first dose at night once stabilised then continue morning Higher risk in HF patient, taking diuretics Discontinue potassium sparing duretics; risk hyperkalaemia
177
ACEi interactions
A2RBs Diuretics Allopurinol NSAIDs Digoxin Lithium
178
Initiation under specialist supervision with ACEi
Severe or unstable HF Pts receiving high doses diuretics Concomitant use of ACE II receptor antagonist or alskiren Known renovascular disease Hyponatraemia Hypotension Pts with hypovolaemia
179
Side effects of ACEi
Dry cough persistent ; consider switching to ARBs Diziness Headaches Abdominal discomfort; constipation, diarrhoea, nausea vomiting Alopecia Angioedema (higher in afro-Caribbean or delayed) Skin reactions Hyperkalaemia
180
ACEi and monitoring
Renal function Electrolytes
181
ARBs
Less likely to cause dry cough E.g candersartan, irbesartan, losartan valsartan Used with ACEi is CI Hypotension, Diziness, hyperkalaemia, oral ulcers, taste disturbances
182
What drugs to avoid in AKI
Nephrotoxic drugs Diuretics, ACEi, Metformin and NSAIDs DAMN
183
Renin inhibitors
Aliskiren Licensed hypertention alone or in combo with other antihypertensives ACEi and aliskiren = hyperkalaemia , hypotension or renal impairment
184
Raynauds syndrome
Blood circulation issue; fingertip and toes change colour Pain numbness, pin/needles, difficulty moving affected area Treat; nifedipine, exercise, keeping warm, stopping smoking
185
Chilblains
Small itchy patches on skin from being out in the cold; worse once you warm up Self limiting; soothing lotion, whitch hazel to relieve the itching
186
Amiodarone side effects
Corneal micro-deposits; night time glare Phototoxicity Slate/grey skin on light exposed areas Peripheral neuropathy; numbness tingly feet etc Pulmonary fibrosis (dry cough), pneumonitis Thyroid dysfunction (contains iodine; hyperthyroid symptoms)
187
Monitoring requirements in amiodarone
Annual eye checks X-ray prior to treatment LFTs ever 6 months TSH levels before treatment and every 6 months BP and ECG Serum potassium
188
Amiodarone interactions
Has a long half life - be aware even if stopped Increase concentrationn with statins and grapefruit juice Interacts QT prolongation drugs; increases ventricular arrhythmias risk Enzyme inhibitors; half dose with digoxin, warfarin and phenytoin Bradycardia, av block ad myocardial depression
189
Chest pain clinical features
Oxygen saturation <92% HR >130 bpm Respiratory rate >30 BPM Altered state consciousness Hyperthermia 38.5 + BP diastolic <60 or systolic <90
190
What does QRISK calculate
CV risk of someone over the next 10 years